Vimarsana
Biggest News Aggregation in the World

Page 21 - Genome Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genome Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genome Sciences Today - Breaking & Trending Today

The new Omicron subtype BA.2 could prolong the current wave of COVID-19 infection, scientists say - Vimarsana News

The new Omicron subtype BA.2 could prolong the current wave of COVID-19 infection, scientists say

Early data suggests the BA.2 Omicron subtype is around 1.5 times more infectious than BA.1, which is the most common subtype in the US. Joe

Racing toward innovation | UNC-Chapel Hill - Vimarsana News

Racing toward innovation | UNC-Chapel Hill

Convergent science is characterized by cross-disciplinary research teams created to tackle big problems and speed the application of new breakthroughs to commercialization. At Carolina, the Institute for Convergent Science is at the forefront of this pioneering framework.

Source: unc.edu
Unhealthy vaginal microbiome in mothers may contribute to infant deaths and altered development - Vimarsana News

Unhealthy vaginal microbiome in mothers may contribute to infant deaths and altered development

A new study in mice from University of Maryland School of Medicine researchers showed that an unhealthy vaginal microbiome in pregnant mothers in combination with an unhealthy diet contributed to increased pup deaths and altered development in the surviving babies.

Microbiome of mother's vagina may affect infant mortality risk and baby's development - Vimarsana News

Microbiome of mother's vagina may affect infant mortality risk and baby's development

A new study in mice from University of Maryland School of Medicine researchers showed that an unhealthy vaginal microbiome in pregnant mothers in

Case Western Reserve University grants exclusive license to Ionis Pharmaceuticals to advance antisense therapy - Vimarsana News

Case Western Reserve University grants exclusive license to Ionis Pharmaceuticals to advance antisense therapy

Case Western Reserve University and Ionis Pharmaceuticals, Inc. have signed an exclusive license agreement to advance and commercialize a therapeutic